Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

U.S. patent issues for Genzyme's pseudo-adenoviral vectors

March 25, 1999

Patent issued to GenVec covering gene delivery systems targeting specific tissues

March 24, 1999

Ariad receives broader patent coverage for its ARGENT and Dimerizer Drugs technologies

March 24, 1999

Genetronics receives CE Mark approval for MedPulser solid tumor treatment

March 24, 1999

Aastrom receives SBIR grant for cord blood transplant program

March 22, 1999

Copernicus Therapeutics receives grant from NCI for novel gene therapy research

March 22, 1999

Vion seeks permission to begin clinical trials of TAPET vectors

March 19, 1999

Genzyme Transgenics and Millennium BioTherapeutics collaborate on transgenic biotherapeutics

March 19, 1999

Structural Bioinformatics achieves research milestone

March 19, 1999

Biovector collaborates with Chiron and Bayer on DNA delivery applications

March 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...